Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0000950170-24-100281

Director sold 105,244 shares at $4.43 ($466,210)

  • Director acquired 105,244 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PAKIANATHAN DEEPIKA · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-22 Exercise or conversion : show line 1 in the form +1,825 $3.00 $5,475 1,825 D
2024-08-22 Exercise or conversion : show line 2 in the form +6,492 $1.84 $11,945 8,317 D
2024-08-22 Exercise or conversion : show line 3 in the form +12,418 $2.72 $33,777 20,735 D
2024-08-22 Exercise or conversion : show line 4 in the form +38,953 $1.31 $51,028 59,688 D
2024-08-22 Exercise or conversion : show line 5 in the form +43,485 $0.94 $40,876 103,173 D
2024-08-22 Exercise or conversion : show line 6 in the form +2,071 $3.87 $8,015 105,244 D
2024-08-22 Sale : show line 7 in the form −105,244 $4.43 $466,210 0 D
Open-market sales · 105,244 sh · avg $4.43 · $466,210

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2024-08-22 Exercise or conversion : show line 8 in the form Share Options (right to buy) −5,500 0 D
2024-08-22 Exercise or conversion : show line 9 in the form Share Options (right to buy) −11,000 0 D
2024-08-22 Exercise or conversion : show line 10 in the form Share Options (right to buy) −31,500 0 D
2024-08-22 Exercise or conversion : show line 11 in the form Share Options (right to buy) −55,000 0 D
2024-08-22 Exercise or conversion : show line 12 in the form Share Options (right to buy) −55,000 0 D
2024-08-22 Exercise or conversion : show line 13 in the form Share Options (right to buy) −15,000 30,000 D
Loading xslF345X05/ownership.xml…